Command Palette

Search for a command to run...

Clinical Trials · NCT01296412

Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)

CompletedPhase 3Liraglutide (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Merck Sharp & Dohme LLC
Enrollment
653
Start date
Mar 2011
Locations
See registry
Primary endpoint
Change From Baseline in Hemoglobin A1c (A1C)
View Liraglutide compound reference